Industry watchers said one of the biggest obstacles when they entrusted contract drug-making to Samsung Biologics was Samsung Bioepis, which develops biosimilars.“By evolving into a dedicated CDMO player, Samsung Biologics will be able to double down on its core growth strategy of expanding production capacity, diversifying its portfolio and strengthening its global footprint,” said a company official.“This includes deeper investments in advanced biologics platforms such as antibody-drug conjugates (ADCs), adeno-associated virus (AAV) vectors and prefilled syringe (PFS) technologies.”SAMSUNG BIOEPIS TO FOCUS ON BIOSIMILARS, NOVEL DRUGSSamsung Bioepis, which has over 20 biosimilar assets under development, has also entered clinical stages for several gene therapy candidates and ADC-based cancer treatments.
Samsung Biologics, the biotechnology unit of South Korea’s top conglomerate Samsung Group, said in a regulatory filing on Thursday that it will establish a new holding company – tentatively named Samsung Epis Holdings – to oversee Samsung Bioepis and other biosimilar and new drug development businesses.
Samsung Biologics Co., the world’s largest contract drugmaker, will undergo a strategic split to separate its contract development and manufacturing organization (CDMO) business from its biosimilar and novel drug development business, currently undertaken by its wholly owned Samsung Bioepis Co.
The story "Samsung Biologics to spin off biosimilar unit Samsung Bioepis" has 639 words across 29 sentences, which will take approximately 3 - 6 minutes for the average person to read.
Which news outlet covered this story?
The story "Samsung Biologics to spin off biosimilar unit Samsung Bioepis" was covered 7 hours ago by Korea Economic Daily, a news publisher based in South Korea.
How trustworthy is 'Korea Economic Daily' news outlet?
Korea Economic Daily is a fully independent (privately-owned) news outlet established in 1964 that covers mostly economy news.
The outlet is headquartered in South Korea and publishes an average of 7 news stories per day.
It's most recent story was published ago.
What do people currently think of this news story?
The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.
How do I report this news for inaccuracy?
You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
